Image Guided and Adaptive Radiotherapy in Clinical Practice: Including SABR Topics
Thank you for your interest in the Image Guided and Adaptive Radiotherapy course. Please note we are no longer taking applications for May 2025.
Course overview
This course is designed to help clinicians, physicists and radiographers to develop comprehensive programmes for the clinical implementation of image guided radiotherapy. The course has been awarded 19 RCR Category I CPD credits under The Royal College of Radiologists CPD scheme.
The curriculum covers many practical aspects and includes hands-on practical sessions, image matching, QA and dosimetry. It is recommended that a team of oncologist, physicist and radiographer from the same centre attend together.
The course is for three days and included in the cost are a set of lecture notes, a digital copy of the actual presentations, lunches, refreshments, cheese and wine and a course dinner on the Thursday evening.
Day one: Introduces multi-modality and functional imaging for the delivery of complex radiotherapy, discusses future developments as well as an introduction to the principles of IGRT, and clinical site implementation.
Day two: Lectures on head and neck, breast, prostate and lung clinical trials, SABR and image verification. FFF and small field dosimetry and QA with SABR.
Day three: Practical hands-on sessions on the use of Image Guidance protocols, QA, Dosimetry, and a journey through the patient pathway.
Downloads
Download the IG-ART Course Flyer 2025 for detailed course information.
Payment options
Invoice payment: please contact Paul Downs for details
BACS/ overseas transfers: please contact: Paul Downs for details
Course organisers
- Ms Margaret Bidmead
- Dr Helen McNair
- Dr Emma Harris
- Ms Sophie Alexander
Contacts
Margaret Bidmead (Course Creator)
Tel: 020 7808 2506
Fax: 020 7808 2522
This course has been accredited under The Royal College of Radiologists CPD scheme.
Related pages
Latest ICR News
Breast cancer test predicts relapse risk in just two weeks – and could spare thousands of patients from unnecessary treatment
Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting treatment.
Targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.